Published in J Biopharm Stat on July 01, 2009
Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) (2011) 2.09
Getting carried away: a note showing baseline observation carried forward (BOCF) results can be calculated from published complete-cases results. Int J Obes (Lond) (2011) 0.96
Examining social influence on participation and outcomes among a network of behavioral weight-loss intervention enrollees. J Obes (2013) 0.90
Time series analysis as input for clinical predictive modeling: modeling cardiac arrest in a pediatric ICU. Theor Biol Med Model (2011) 0.89
A closer look at the baseline-observation-carried-forward (BOCF). Patient Prefer Adherence (2010) 0.88
Time to first cigarette predicts cessation outcomes in adolescent smokers. Nicotine Tob Res (2013) 0.88
Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain. Eur J Pain (2015) 0.87
Weight outcomes audit in 1.3 million adults during their first 3 months' attendance in a commercial weight management programme. BMC Public Health (2015) 0.81
Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol. BMJ Open (2014) 0.78
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med (2005) 1.99
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? Int Clin Psychopharmacol (2006) 1.08
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. Pain Med (2007) 0.93
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berl) (2011) 0.91
Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain. Diabetes Care (2007) 0.90
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. Int Clin Psychopharmacol (2008) 0.87
Collapsing mechanistic models: an application to dose selection for proof of concept of a selective irreversible antagonist. J Pharmacokinet Pharmacodyn (2005) 0.87
Minimum significant ratio of selectivity ratios (MSRSR) and confidence in ratio of selectivity ratios (CRSR): quantitative measures for selectivity ratios obtained by screening assays. J Biomol Screen (2012) 0.81
Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease. Alzheimer Dis Assoc Disord (2015) 0.78
On the treatment effect in clinical trials with dropout. J Biopharm Stat (2006) 0.75